| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213278 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 31 Pages |
Abstract
The PBT clinical trial portfolio is expanding rapidly. Although the majority of ongoing studies are interventional, the majority of patients will be accrued to observational studies. Future efforts should focus on strategies to encourage optimal patient enrollment and retention, with an emphasis on randomized, controlled trials, which will require support from third-party payers. Results of ongoing PBT studies should be evaluated in terms of comparative effectiveness, as well as incremental effectiveness and value offered by PBT in comparison with conventional radiation modalities.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mark V. MD, Sameer MD, Soren M. PhD, DMSc, Nancy PhD, Minesh P. MD, William F. MD, FACR, FACRO,
